Uppsala Monitoring Centre is a dynamic non-profit organization with the mission of improving the safety of medicines throughout the world. By managing and analyzing VigiBase, WHO’s global database of reported potential side effects of medicinal products, consisting of more than 35 million reports from patients and health care professionals in more than 150 countries, UMC has a unique role in detecting the adverse effects of medicines, for which it is recognized internationally.
UMC is opening master thesis positions for 2024. We are looking for creative and motivated students with a keen interest in data science or software development. We have three ideas for possible theses within the field of information technology.
Please note that these theses proposals are not fully complete! Together with you, we will discuss the ideas further to tailor them for you.
Thesis 1: Automating Adverse Event Reporting in Healthcare
Are you interested in improving the efficiency and accuracy of reporting adverse events in the healthcare sector? Do you want to learn how to use cutting-edge tools to automate the process of digitizing paper forms? If yes, then you might want to check out this thesis project.
The project will compare different tools that can recognize handwritten text from paper forms and convert them into digital data. You would evaluate these tools based on three criteria:
By doing this project, you will gain valuable skills and knowledge in using modern technologies to solve real-world problems. You will also contribute to the advancement of healthcare quality and safety by reducing human errors and delays in reporting adverse events.
Thesis 2: Climate-Aware Decision Support for Azure Resource Selection: A Multifaceted Approach
This master thesis aims to bridge the gap between environmental responsibility and operational efficiency within IT organizations. By developing a holistic decision support tool, it empowers organizations to make informed choices that consider climate impact without compromising on their budget and functional needs. Furthermore, it offers a step toward a more sustainable IT landscape, aligning with the growing demand for ecologically responsible business practices. The suggestion is to use the data provided by Gaia Gen to create a decision support for the development teams, as well as architects and infrastructure leads, when making decisions on what services and resources to use at the UMC. This tool would also consider other important aspects of this decision, such as functionality, security, and budget.
Questions to answer include:
Thesis 3: Preprocessing drug information
When coding big data sets of drug information, an important first step is preprocessing. Successful preprocessing can eliminate repetitive tasks and allow the experts examining the data more time to review the more complex information.
This master thesis aims to improve our preprocessing of drug information. In one of our applications, we import a lot of drug information. Before our pharmacists can review this information, they need to code active ingredient and Market Authorization Holder to our standardized dictionary. This process often requires the pharmacist to correct spelling mistakes and remove unnecessary information.
paracetamol 200 mg -> Paracetamol
Astra Zeneca AB (Sweden) -> Astra Zeneca
A suggested technique for this problem would be to use a Machine learning algorithm trained on our previously coded drug information.
Please include which theses/thesis you are interested in, in your application
Techniques that may be used depending on the project:
Benefits for you:
Who you are:
Real-world impact – Working for the greater good
Learning organisation – Skilled and curious staff
Flexible work hours – Allows us to be at our best
Uppsala Monitoring Centre (UMC) is a centre for international service and scientific research in the field of pharmacovigilance. We are the WHO Collaborating Centre for International Drug Monitoring, and manage the technical and operational aspects of the WHO Programme for International Drug Monitoring since 1978.
As an independent, non-profit foundation, we support the World Health Organization, regulatory authorities, and other stakeholders who share our vision of advancing medicines safety. Through research and development of new scientific methods, we explore the benefits and harms of medicines for patients, and offer products and services used by health authorities and the pharmaceutical industry worldwide.
UMC follows the collective agreements between the Swedish Agency for Government Employers and Saco-S and ST. Union representatives are Malin Zaar (Saco-S) and Jessica Avasol (ST), +46 (0)18-65 60 60.